跳到主要內容
big screen image small screen image
Font Size
A
A
A
轉寄 轉寄
(Exclusive License) Technology Transfer Enterprise Selection Announcement - A Novel Method for Genotyping the Human Leukocyte Antigen (HLA) Genes: Probe-based Capture and Next-generation Sequencing
Date of Announcement
2020-12-29
 

Subject

(Exclusive License) Technology Transfer Enterprise Selection Announcement - A Novel Method for Genotyping the Human Leukocyte Antigen (HLA) Genes: Probe-based Capture and Next-generation Sequencing

Content

  • Technology:

A Novel Method for Genotyping the Human Leukocyte Antigen (HLA) Genes: Probe-based Capture and Next-generation Sequencing

  • Provider:

Professor Pei-Lung Chen/ Graduate Institute of Medical Genomics and Proteomics

  • Enterprise Eligibility

1. Industry Category: Medical devices, genomics or pharmacogenomics

2. Required Technical Know-how: Technology of molecular biology and certification of medical devices

3. Required Machinery and Equipment: Equipment for the manufacturing of medical devices and reagents

4. Required Research or Technical Staff: Molecular biology, genomics, and medical devices personnel

5. Other Requirements: No specific restrictions

 

The university's regulations relevant to technology transfer shall be complied with for matters not aforementioned.

 

  • How to apply? Please go to the Center of Industry-Academia Collaboration of the Office of Research and Development to inquire about relevant information.

Contact Person

Winston Pan

TEL: +886-2-33669951

Email: lutepan@ntu.edu.tw

File download:
Technology Transfer Enterprise Selection Announcement - A Novel Method for Genotyping the Human Leukocyte Antigen (HLA) Genes: Probe-based Capture and Next-generation Sequencing
File size: 1356kb